HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Re-inspection Fees, Spiked Coffee, Recalls: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Nearly $500,000 In re-inspection fees uncollected; ED drugs In AMPT Life coffee ; and more protein bars caught In Listeria-contamination recall.

You may also be interested in...



FDA Budget Request Signals Importance Of Boosting Food Safety Programs

"You begin to see FDA telegraphing that this is important. That was lacking in the past two budgets," said Mike Greene, Council for Responsible Nutrition's chief congressional liaison. White House's budget request recommends $67m increase from FY 2019 to $1.4bn for FDA's food industry programs in CFSAN, which includes the Office of Dietary Supplement Programs, and for the Office of Regulatory Affairs' related field activities.

Recalls, Investments, Verifications: Health And Wellness Industry News

Supplements spiked with ED drugs recalled; Agritek Holdings purchases nutrition and supplement marketer Performance Nutrition Center; more dietary supplement recalls and other news in brief.

Nut Ingredient Listeria Contamination Leads To More Protein Bar Recalls

Health Warrior, ISS One and Amrita brand proteins made with HVF-supplied nut ingredients are class I recalls.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel